PE20130782A1 - Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo - Google Patents

Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo

Info

Publication number
PE20130782A1
PE20130782A1 PE2012002483A PE2012002483A PE20130782A1 PE 20130782 A1 PE20130782 A1 PE 20130782A1 PE 2012002483 A PE2012002483 A PE 2012002483A PE 2012002483 A PE2012002483 A PE 2012002483A PE 20130782 A1 PE20130782 A1 PE 20130782A1
Authority
PE
Peru
Prior art keywords
paracetamol
preparation
same
pharmaceutical compositions
compositions consisting
Prior art date
Application number
PE2012002483A
Other languages
English (en)
Inventor
Ketan R Patel
Milan R Patel
Prakaskashchandra Shah
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44514837&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20130782(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Publication of PE20130782A1 publication Critical patent/PE20130782A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION PARENTERAL QUE CONTIENE: A)PARACETAMOL EN UNA CONCENTRACION ACTIVA EN EL RANGO DE 166 A 250 mg/ml; B) UN SISTEMA DE DISOLVENTE QUE COMPRENDE GLICOFEROL DE 25 A 42% (V/V), ETANOL 10 A 37% (V/V),POLIETILENGLICOL 3 A 19% (V/V), Y AGUA CSP 2-3ml. TAMBIEN SE REFIERE A UN PROCESO FARMACEUTICO. DICHA COMPOSICION TIENE DOSIS TERAPEUTICAS DE PARACETAMOL UTIL EN EL TRATAMIENTO DE LA FIEBRE Y EL DOLOR, CON VISCOSIDAD DE 7 A 28 CPS, ADECUADA PARA LA ADMINISTRACION INTRAMUSCULAR E INTRAVENOSA.
PE2012002483A 2010-06-30 2011-06-29 Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo PE20130782A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3023MU2009 2010-06-30
IN630MU2010 2010-09-09

Publications (1)

Publication Number Publication Date
PE20130782A1 true PE20130782A1 (es) 2013-06-20

Family

ID=44514837

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2017000257A PE20170426A1 (es) 2010-06-30 2011-06-29 Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo
PE2012002483A PE20130782A1 (es) 2010-06-30 2011-06-29 Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2017000257A PE20170426A1 (es) 2010-06-30 2011-06-29 Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo

Country Status (26)

Country Link
US (1) US9616128B2 (es)
EP (1) EP2588097B1 (es)
JP (1) JP5872551B2 (es)
KR (1) KR101587942B1 (es)
CN (1) CN102958519B (es)
AP (1) AP3932A (es)
AR (1) AR083154A1 (es)
AU (1) AU2011273064B2 (es)
BR (1) BR112012031928B1 (es)
CA (1) CA2802303C (es)
CO (1) CO6592023A2 (es)
CU (1) CU20120178A7 (es)
DK (1) DK2588097T3 (es)
EA (1) EA023022B1 (es)
ES (1) ES2866636T3 (es)
HU (1) HUE054171T2 (es)
IL (1) IL222780A (es)
MX (1) MX2012014800A (es)
MY (1) MY156469A (es)
PE (2) PE20170426A1 (es)
PL (1) PL2588097T3 (es)
PT (1) PT2588097T (es)
TW (1) TWI538673B (es)
UA (1) UA109544C2 (es)
WO (1) WO2012001494A2 (es)
ZA (1) ZA201209674B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121154A1 (it) * 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
JP6741286B2 (ja) * 2013-03-28 2020-08-19 テルモ株式会社 包装されたアセトアミノフェン注射液製剤の製造方法
US11266621B1 (en) 2014-10-02 2022-03-08 Exela Sterile Medicines Llc Methocarbamol composition and related methods
CA2969303A1 (en) 2014-12-20 2016-06-23 Troikaa Pharmaceuticals Limited Injectable formulations of paracetamol
WO2022178018A1 (en) * 2021-02-19 2022-08-25 Nevakar Injectables Inc. Liquid unit dosage forms for treatment of pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060052757A1 (en) * 1996-06-04 2006-03-09 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with analgesic or anesthetic
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
DE69719189T2 (de) 1997-11-18 2003-11-27 Uni Pharma Kleon Tsetis A B E Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
IT1301976B1 (it) * 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
DK1105141T3 (da) * 1998-08-06 2004-03-08 Wolfgang Stremmel Phosphatidylcholin som et medikament med slimhindebeskyttende virkning
IT1313579B1 (it) * 1999-07-30 2002-09-09 Acraf Composizione farmaceutica liquida a base di paracetamolo.
EP1363602A4 (en) * 2001-01-25 2006-01-11 Euro Celtique Sa LOCAL ANESTHESIA, AND METHOD OF USE
EP2170313A2 (en) * 2007-06-18 2010-04-07 Combino Pharm, S.L. Aqueous formulations of acetaminophen for injection
FR2926992B1 (fr) 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution

Also Published As

Publication number Publication date
PE20170426A1 (es) 2017-04-12
BR112012031928A2 (pt) 2017-06-20
BR112012031928B1 (pt) 2021-08-31
AP2012006645A0 (en) 2012-12-31
EP2588097B1 (en) 2021-02-24
US9616128B2 (en) 2017-04-11
AR083154A1 (es) 2013-02-06
WO2012001494A3 (en) 2012-05-18
TWI538673B (zh) 2016-06-21
CA2802303C (en) 2016-06-14
ZA201209674B (en) 2013-09-25
IL222780A (en) 2017-08-31
CO6592023A2 (es) 2013-01-02
EA201291433A1 (ru) 2013-05-30
TW201206420A (en) 2012-02-16
ES2866636T3 (es) 2021-10-19
KR20130100243A (ko) 2013-09-10
PT2588097T (pt) 2021-05-25
DK2588097T3 (da) 2021-05-10
AP3932A (en) 2016-12-16
KR101587942B1 (ko) 2016-01-22
CU20120178A7 (es) 2013-03-27
IL222780A0 (en) 2012-12-31
JP5872551B2 (ja) 2016-03-01
EA023022B1 (ru) 2016-04-29
HUE054171T2 (hu) 2021-08-30
US20130096201A1 (en) 2013-04-18
JP2013529675A (ja) 2013-07-22
AU2011273064B2 (en) 2014-01-09
CN102958519B (zh) 2016-01-13
PL2588097T3 (pl) 2021-09-06
EP2588097A2 (en) 2013-05-08
MY156469A (en) 2016-02-26
CA2802303A1 (en) 2012-01-05
MX2012014800A (es) 2013-01-29
WO2012001494A2 (en) 2012-01-05
CN102958519A (zh) 2013-03-06
UA109544C2 (uk) 2015-09-10

Similar Documents

Publication Publication Date Title
AR110986A2 (es) Composiciones de ecteinascidina, formulaciones liofilizadas, método de preparación y uso
HRP20180007T1 (hr) Formulacija koja sadrži gemcitabin-predlijek
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
CL2019000245A1 (es) Moduladores nmda espiro-lactam y métodos de uso de los mismos.
EA200501203A1 (ru) Жидкие фармацевтические композиции палоносетрона
AR101674A1 (es) Uso de un compuesto tricíclico que contiene nitrógeno
ECSP14023048A (es) Agentes terapéuticos para administración subcutánea optimizados
PE20130782A1 (es) Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo
ECSP16084317A (es) Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
PE20181332A1 (es) Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos
AR062659A1 (es) Composicion de liberacion sostenida de levodopa y metodo para su uso
CO6771406A2 (es) Una composición combinada
CY1124893T1 (el) Φαρμακευτικο μeιγμα μαροπιταντης
WO2015009731A3 (en) Azacyclic constrained analogs of fty720
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
CO6470840A2 (es) Formas farmacéuticas solubles de la n, n´-diaminodifenilsulfona para uso óptimo en el tratamiento de diversas enfermedades
PH12017501005A1 (en) Injectable formulations of paracetamol
MX2018015759A (es) Regimenes de dosificacion de vortioxetina para el rapido inicio del efecto antidepresivo.
AR074470A1 (es) Compuesto de amida del acido ciclopropanocarboxilico, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de diabetes
MXPA06000760A (es) Composicion farmaceutica estable de carisoprodol y meloxicam.
AR105087A1 (es) Métodos para el tratamiento de mujeres con trastorno de deseo sexual hipoactivo (hsdd) con el tratamiento de combinación bupropión y trazodona
AR115724A1 (es) Composición farmacéutica que contiene un péptido
EA201592261A1 (ru) Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой
BR112015022925A8 (pt) Partículas de liberação estendida de resinato de fenilefrina, formulação farmacêutica, complexo de fármaco-resina e seu método de formação
CO2019013645A2 (es) Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas

Legal Events

Date Code Title Description
FC Refusal